Joel D. Schilling, MD, PhD

Joel D. Schilling, MD, PhD

Associate Professor of Medicine, Immunology/Pathology

Related Links

Schilling Lab

Physician Profile

Research Profile

Education

  • BA, Chemistry: Colorado College, Colorado Springs, CO (1996)
  • MD, PhD, Medicine/Immunology: Washington University School of Medicine, St. Louis, MO (2003)
  • Internship and Residency, Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2005)
  • Fellowship, Cardiology: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2007)
  • Fellowship, Advanced Heart Failure and Cardiac Transplantation: Washington University School of Medicine, St. Louis, MO (2009)

Board Certifications

  • Cardiovascular Medicine
  • Advanced Heart Failure
  • Cardiac Transplant

Recognition

  • Finalist, Northwestern Cardiovascular Young Investigators Forum, 2011
  • Burton Sobel Award for Excellence in Cardiovascular Research, 2009
  • Jay Cohn New Investigator Award, Heart Failure Society of America, 2009
  • Knowlton Award for Clinical Excellence, 2007
  • Resident of the Year Award, Internal Medicine, 2005
  • The William Peck Book Award in Internal Medicine, awarded in recognition of the highest achievement in internal medicine, 2003
  • David F. Silbert Outstanding Teaching Assistant Award, 2000

Clinical Interests

outpatient and inpatients management of congestive heart failure, pre- and post-heart transplant care, advanced heart failure, heart failure in diabetic patients

Research Interests

The Schilling laboratory studies the role of diverse resident and recruited macrophage subsets in the pathogenesis of metabolic liver diseases, such as metabolic associated steatotic liver disease (MASLD), and in liver dysfunction associated with right heart failure.  The combination of mouse models and human tissue samples in conjunction with single cell transcriptomics, flow cytometry, tissue imaging, and ex vivo models are utilized to address important questions in the pathogenesis and treatment of these liver disease.